June 2012

F. Xavier Bosch, Lilly Foundation for Biomedical Research award 2012

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Infections and Cancer / By

Delivery of the Lilly Foundation for Biomedical Research award 2012 F. Xavier Bosch, researcher at IDIBELL/ICO and world leader in human papilloma virus and cervical cancer, has received the Lilly Foundation for Biomedical Research award 2012 in the preclinical research category. Dr. Felipe Casanueva, scientific director of CIBERobn, who has contributed to international understanding of […]

F. Xavier Bosch, Lilly Foundation for Biomedical Research award 2012 Read More »

Manel Esteller receives a Merck Serono Research grant

Leave a Comment / Cancer Epigenetics / By

Dr. Manel Esteller, from the Bellvitge Biomedical Research Institute (IDIBELL), has received a Merck Serono Research grant in the research area in molecular basis of rare diseases and their clinical implications for the project “Epigenetic characterization of Sotos Syndrome. Evaluation of the pharmacological treatments use aimed at enhancing the expression of microRNAs”. After 20 years,

Manel Esteller receives a Merck Serono Research grant Read More »

The Ramon Areces Foundation funds UB and IDIBELL research projects

Leave a Comment / Cancer Epigenetics / By

A project of Dr. Esteban Ballestar, from IDIBELL, funded by the Ramón Areces Foundation The Ramon Areces Foundation funded several research projects of UB and IDIBELL, through the Sixteenth Call of the Spanish National Competition. The act of delivery of the aid took place last June 27th at the headquarters of this organization in Madrid,

The Ramon Areces Foundation funds UB and IDIBELL research projects Read More »

Bacterial translocation in cirrhotic patients: relationship with renal insufficiency and prognosis

Leave a Comment / Sin categorizar / By

IDIBELL Seminars. June 15, 2012. At the conference Dr José Such, from the Liver Unit of the General University Hospital of Alicante and CIBERehd, and specialized in bacterial translocation in cirrhotic patients, spoke of translocation and clinical effects. “The cirrhosis causes portal hypertension, which can lead to splanchnic vasodilation, all of which can cause the

Bacterial translocation in cirrhotic patients: relationship with renal insufficiency and prognosis Read More »

Bellvitge researchers develop new method to reduce length of stay for patients with pneumonia

Leave a Comment / Infections of the Respiratoy Tract and in Immunocompromised Patients , Infectious disease and transplantation Program, Translational Medicine Area / By

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have found a new safe and effective method to reduce the duration of intravenous antibiotic therapy and the length of hospital stay for patients with community-acquired pneumonia. This strategy would help to optimize the care of hospitalized patients with pneumonia and reduce the hospital costs. In Europe,

Bellvitge researchers develop new method to reduce length of stay for patients with pneumonia Read More »

The Clinical Research Ethics Committee of Bellvitge announces its work

Leave a Comment / Sin categorizar / By

The Clinical Research Ethics Committee (CEIC) of the Bellvitge University Hospital was held on June 11th of an extraordinary session addressed to professionals interested in biomedical research, including basic and clinical researchers with the aim of introducing their work and exploring new avenues of communication with the scientific community.

The Clinical Research Ethics Committee of Bellvitge announces its work Read More »

The IDIBELL among the finest research institutions in Spain

Leave a Comment / Sin categorizar / By

The IDIBELL ranks fifth in a ranking of research institutions in Spain in a study published this week by the Fundación Conocimiento y Desarrollo (Knowledge and Development Foundation). Furthermore, the Catalan Institute of Oncology from Hospitalet, partner of IDIBELL, ranks second and, among universities, UB appears in first position. This study collects data from scientific

The IDIBELL among the finest research institutions in Spain Read More »

The epigenome of newborns and centenarians is different

Leave a Comment / Sin categorizar / By

An international study coordinated by Manel Esteller check how epigenetic marks are degrading over time. Since epigenetic lesions are reversible, it would be possible to develop drugs that increase the life span What happens in our cells after one hundred years? What is the difference at the molecular level between a newborn and a centenary?

The epigenome of newborns and centenarians is different Read More »

Walk On Project” funds an IDIBELL project with almost 100,000 euros

Leave a Comment / Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

The Walk on Project (WOP) nonprofit foundation, in collaboration with BBK Fundazioa, will fund with 98,000 euros a research project led by Dr. Aurora Pujol, ICREA research professor in Bellvitge Institute for Biomedical Research (IDIBELL), who is an expert in Human Genetics and Neurodegenerative Diseases. The project, entitled “Pharmacological strategies for the regeneration of myelin

Walk On Project” funds an IDIBELL project with almost 100,000 euros Read More »

Alfredo García, new Director of Bellvitge Hospital

Leave a Comment / Sin categorizar / By

Dr. Alfredo Garcia Diaz has been appointed managing director of the Bellvitge University Hospital and managing director of the South Metropolitan Territorial Management of the Catalan Institute of Health. Replaced in this role Dr. Xavier Corbella, who has been appointed manager of the Hospital Santa Creu i Sant Pau in Barcelona.

Alfredo García, new Director of Bellvitge Hospital Read More »

Scroll to Top